SCHEMBL5192203

SCHEMBL5192203

COc1ccc(-c2ccc(C(=O)N[C@H](C(=O)OC(C)(C)C)C3CCCCC3)c(N)c2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP13 P45452 7/20 0.46
MMP1 P03956 6/20 0.45
MMP3 P08254 6/20 0.45
MMP7 P09237 6/20 0.45
MMP2 P08253 5/20 0.45
CNR1 P21554 2/20 0.42
CNR2 P34972 2/20 0.42
AAK1 Q2M2I8 1/20 0.42
MMP9 P14780 3/20 0.41
MMP8 P22894 3/20 0.41
ALDH1A1 P00352 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CTSL P07711 1/20 0.40
CTSS P25774 1/20 0.40
CTSK P43235 1/20 0.40
CACNA1B Q00975 1/20 0.39
HSP90AA1 P07900 1/20 0.38
HSP90AB1 P08238 1/20 0.38
NPR3 P17342 1/20 0.37
NPC1 O15118 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5194761 0.91 PYGL (0.39) MMP13MMP1MMP3MMP7MMP2
SCHEMBL5423348 0.88 MMP13 (0.56) MMP13MMP1MMP3MMP7MMP2
SCHEMBL5197189 0.87 MMP13 (0.38) MMP13AAK1ALDH1A1NPR3
SCHEMBL5194286 0.87 MMP13 (0.54) MMP13MMP1MMP3MMP7MMP2
SCHEMBL5192366 0.84 KDM4E (0.48) MMP13AAK1ALDH1A1CTSLCTSK
SCHEMBL5194502 0.81 KMT2A (0.39) MMP13MMP1MMP3MMP7MMP2
SCHEMBL5431737 0.78 MAPK1 (0.41) MMP1ALDH1A1SMN1; SMN2CACNA1BNPC1
SCHEMBL5192018 0.77 MMP13 (0.41) MMP13MMP1MMP3MMP7MMP2
SCHEMBL5192008 0.77 MMP13 (0.41) MMP13MMP1MMP3MMP7MMP2
SCHEMBL5422392 0.76 MAPK1 (0.41) MMP1ALDH1A1SMN1; SMN2CACNA1BNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1812383-A1 GLYCOGEN PHOSPHORYLASE INHIBITOR COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF Smithkline Beecham Corporation (US) 2007-08-01 EP disclosed
WO-2006052722-A1 GLYCOGEN PHOSPHORYLASE INHIBITOR COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF SMITHKLINE BEECHAM CORPORATION (US) 2006-05-18 WO disclosed